Svaki investicijski projekt temelj je razvoja društva, kao i kreiranje novih vrijednosti. Želja investitora jest ostvarivanje maksimalnog profita ulaganjima u investiciju. Da bi došlo do ulaganja u investiciju i donošenja odluke, potrebna je ocjena investicijskog projekta. Ona se provodi uz pomoć više kriterija ekonomsko-financijskog odlučivanja. Polazeći od tih kriterija, ovim je radom prikazan izračun neto sadašnje vrijednosti, relativne neto sadašnje vrijednosti, interne stope profitabilnosti, analize osjetljivosti, sve u cilju prikaza isplativosti i opravdanosti donošenja odluke o realizaciji investicijskog projekta u farmaceutskoj industriji. Donošenje ispravnih i pravovremenih odluka o investicijskim projektima prilika je za razvoj i ekspanziju tvrtke. To se pogotovo odnosi na farmaceutsku industriju u kojoj velik utjecaj na rad poslovanja imaju državna tijela i agencije. Pod pritiskom razvoja tržišta i jake konkurencije u farmaceutskoj su industriji uprave tvrtki prisiljene na donošenje brzih odluka u područjima razvoja poslovanja, što im omogućavaju novi osmišljeni investicijski projekti. Zbog toga je vrlo važno što realnije pretpostaviti podatke pri planiranju investicijskog projekta. U slučaju odabira i realizacije pogrešnih investicijskih projekata tvrtke se mogu dovesti do značajnih gubitaka, odljeva resursa i stečaja. Kroz pozitivan rezultat u radu prikazana je opravdanost ulaganja u novi investicijski projekt, ulaganja u realnu imovinu. U prilog tome provedena je i analiza osjetljivosti investicijskog projekta.

Every investment project is a basis for development of the society and creating new values. The investor's goal is a profit maximization through investments. In order to realize the investment and make the decision, the investment project needs to be evaluated, which is done by several economic and financial evaluation criteria. Starting off with the economic and financial evaluation criteria, the calculation of the current net value, relative current net value, internal profit rate and sensitivity analysis are shown in this paper in order to show profitability and validity of making the decision about realization of investment project in pharmaceutical industry. Making correct and timely decisions about investment projects is an opportunity for development and expansion of the company, which especially applies to the pharmaceutical industry, as its business is greatly influenced by the governing bodies and agencies. Under pressure of market development and strong competition in pharmaceutical industry, managements of the companies are forced to make quick decisions in segments of business development, which is enabled through newly designed investment projects. Therefore, it is of utmost importance to assume data while planning the investment project as realistically as possible. In case of choosing and realizing the wrong investment projects, the companies can bring themselves to significant losses, resources outflow and bankruptcy. Through positive results a justification for investment projects and investments in real assets are shown, and additionally the investment project sensitivity analysis is also implemented.